Mohit Narang
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 53
- Multiple Myeloma Research and Treatments 46
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 3
- Oncology 22
- Cancer Treatment and Pharmacology 14
- Peptidase Inhibition and Analysis 5
- Co-authors
- Robert M. Rifkin (47 shared papers)Rafat Abonour (42 shared papers)James W. Hardin (37 shared papers)Kathleen Toomey (42 shared papers)Amani Kitali (20 shared papers)Shankar Srinivasan (26 shared papers)Howard R. Terebelo (40 shared papers)Cristina Gasparetto (30 shared papers)
- Journals
- Blood (16 papers)Journal of Clinical Oncology (15 papers)British Journal of Haematology (3 papers)American Journal of Hematology (2 papers)Supportive Care in Cancer (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Mohit Narang
62 papers receiving 547 citations
Peers
Comparison fields: 5 of 51
- Hematology 442
- Oncology 198
- Genetics 58
- Molecular Biology 219
- Public Health, Environmental and Occupational Health 62
Countries citing papers authored by Mohit Narang
This map shows the geographic impact of Mohit Narang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohit Narang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohit Narang more than expected).
Fields of papers citing papers by Mohit Narang
This network shows the impact of papers produced by Mohit Narang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohit Narang. The network helps show where Mohit Narang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohit Narang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 65 | |
| 2 | 2019 | 51 | |
| 3 | 2017 | 43 | |
| 4 | 2017 | 31 | |
| 5 | 2018 | 31 | |
| 6 | 2018 | 29 | |
| 7 | 2014 | 28 | |
| 8 | 2018 | 27 | |
| 9 | 2003 | 21 | |
| 10 | 2020 | 21 | |
| 11 | 2009 | 13 | |
| 12 | 2019 | 12 | |
| 13 | 2019 | 12 | |
| 14 | 2018 | 12 | |
| 15 | 2019 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2022 | 11 | |
| 18 | 2016 | 10 | |
| 19 | 2022 | 10 | |
| 20 | 2019 | 9 |
About Mohit Narang
Mohit Narang is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Epidemiology, having authored 66 papers that have together received 566 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (46 papers), Cancer Treatment and Pharmacology (14 papers), Protein Degradation and Inhibitors (9 papers), Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Peptidase Inhibition and Analysis (5 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Hematology (442 citations), Oncology (198 citations), Genetics (58 citations), Molecular Biology (219 citations) and Public Health, Environmental and Occupational Health (62 citations). Mohit Narang has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Robert M. Rifkin, Rafat Abonour, James W. Hardin, Kathleen Toomey, Amani Kitali, Shankar Srinivasan, Howard R. Terebelo, Cristina Gasparetto, Brian G.M. Durie and Sundar Jagannath. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, American Journal of Hematology and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.